IGF-I signalling in bone growth: inhibitory actions of dexamethasone and IL-1beta
- PMID: 17590365
- DOI: 10.1016/j.ghir.2007.05.002
IGF-I signalling in bone growth: inhibitory actions of dexamethasone and IL-1beta
Abstract
Objective: To determine if glucocorticoids and proinflammatory cytokines inhibit bone growth through a common mechanism involving impaired IGF-I signalling.
Design: IGF-I (100 ng/ml), dexamethasone (dex) (10(-6)M) and IL-1beta (10 ng/ml) with inhibitors of the PI3K (LY294002) and Erk 1/2 (PD98059 and UO126) IGF-I pathways (all 10 microM) were studied using the ATDC5 chondrocyte cell line and murine fetal metatarsal cultures.
Results: IGF-I stimulated ATDC5 chondrocyte proliferation (322%; P < 0.001 versus control). Addition of PD or LY individually to IGF-I supplemented ATDC5 cultures partially reduced proliferation by 32% (P < 0.001), and 66% (P < 0.001), respectively. PD and LY in combination blocked all IGF-I stimulated ATDC5 proliferation. LY significantly reversed IGF-I stimulatory effects on metatarsal growth (P < 0.001), whereas PD and UO treatment had no effect. IGF-I induced ATDC5 proliferation was further decreased when Dex (24%; P < 0.01) or IL-1beta (33%; P < 0.001) were added to PD but not LY cultures. Metatarsal growth inhibition by LY was unaltered by Dex or IL-1beta addition.
Conclusions: Both the PI3K and Erk 1/2 pathways contributed independently to IGF-I mediated ATDC5 proliferation. However in metatarsal cultures, the Erk 1/2 pathway was not required for IGF-I stimulated growth. Dex and IL-1beta may primarily inhibit IGF-I induced bone growth through the PI3K pathway.
Similar articles
-
Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent.J Endocrinol. 2006 Nov;191(2):369-77. doi: 10.1677/joe.1.06958. J Endocrinol. 2006. PMID: 17088406
-
Insulin-like growth factor-I augments chondrocyte hypertrophy and reverses glucocorticoid-mediated growth retardation in fetal mice metatarsal cultures.Endocrinology. 2004 May;145(5):2478-86. doi: 10.1210/en.2003-1435. Epub 2004 Jan 28. Endocrinology. 2004. PMID: 14749359
-
Interleukin-1beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones.J Bone Miner Res. 2004 Nov;19(11):1805-12. doi: 10.1359/JBMR.040805. Epub 2004 Aug 16. J Bone Miner Res. 2004. PMID: 15476580
-
Role of insulin-like growth factor-1 in the regulation of skeletal growth.Curr Osteoporos Rep. 2012 Jun;10(2):178-86. doi: 10.1007/s11914-012-0100-9. Curr Osteoporos Rep. 2012. PMID: 22544603 Review.
-
Inhibitory actions of glucocorticoids on skeletal growth. Is local insulin-like growth factor I to blame?Endocrinology. 1998 Jul;139(7):3041-2. doi: 10.1210/endo.139.7.6169. Endocrinology. 1998. PMID: 9645673 Review. No abstract available.
Cited by
-
Multiple roles of the SO4(2-)/Cl-/OH- exchanger protein Slc26a2 in chondrocyte functions.J Biol Chem. 2014 Jan 24;289(4):1993-2001. doi: 10.1074/jbc.M113.503466. Epub 2013 Dec 3. J Biol Chem. 2014. PMID: 24302720 Free PMC article.
-
Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate.Int J Mol Sci. 2017 Aug 31;18(9):1878. doi: 10.3390/ijms18091878. Int J Mol Sci. 2017. PMID: 28858208 Free PMC article. Review.
-
Assessment of Growth Disturbance in Japanese Children with IBD.Int J Pediatr. 2010;2010:958915. doi: 10.1155/2010/958915. Epub 2010 May 5. Int J Pediatr. 2010. PMID: 20454571 Free PMC article.
-
FGF-2 promotes osteocyte differentiation through increased E11/podoplanin expression.J Cell Physiol. 2018 Jul;233(7):5334-5347. doi: 10.1002/jcp.26345. Epub 2018 Jan 23. J Cell Physiol. 2018. PMID: 29215722 Free PMC article.
-
A protective role for FGF-23 in local defence against disrupted arterial wall integrity?Mol Cell Endocrinol. 2013 Jun 15;372(1-2):1-11. doi: 10.1016/j.mce.2013.03.008. Epub 2013 Mar 21. Mol Cell Endocrinol. 2013. PMID: 23523568 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
